Correspondence on Editorial regarding “Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” |
Shunda Du1, Karin Wisskirchen2, Ke Zhang2, Ulrike Protzer3 |
1Department of Liver Surgery, Peking Union Medical College Hospital, PUMC, and Chinese Academy of Medical Sciences 2SCG Cell Therapy Pte. Ltd. 3Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Munich, Munich, Germany |
Correspondence : |
Shunda Du , Tel: 86-10-69152836, Fax: 86-10-69156043, Email: dushd@pumch.cn Ulrike Protzer , Tel: 49-89-4140 6821, Fax: 49-89-4140 6823, Email: protzer@tum.de |
|
Received: September 23, 2024 Revised: October 12, 2024 Accepted: October 20, 2024 |
|
|
|